VKTX — Viking Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeLarge CapHigh Flyer

Annual balance sheet for Viking Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	276	248	202	155	362
Prepaid Expenses
Total Current Assets	284	256	211	167	367
Net Property, Plant And Equipment	0.598	0.321	0.025	1.42	1.13
Other Long Term Assets
Total Assets	284	257	211	169	368
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	6.78	12.1	8.78	21.9	19.1
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	7.14	12.2	8.78	23.2	20.1
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	277	244	202	145	348
Total Liabilities & Shareholders' Equity	284	257	211	169	368
Total Common Shares Outstanding